AIM
TECH icon

ARK Investment Management’s Bio-Techne TECH Stock Holding History

ARK Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,584
Closed -$146K – 330
2022
Q2 		$146K Sell
1,584
-72
-4% -$6.75K ﹤0.01% 302
2022
Q1 		$179K Buy
1,656
+152
+10% +$15.7K ﹤0.01% 325
2021
Q4 		$195K Buy
+1,504
New +$184K ﹤0.01% 331

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

ARK Investment Management's TECH Position: Q3 2022 in Review

ARK Investment Management sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 1,584 shares — an estimated $146K sold.

ARK Investment Management first reported a position in TECH in Q4 2021 and held it in 3 quarters. The position peaked at $195K in Q4 2021. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • ARK Investment Management reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • ARK Investment Management sold 1,584 Bio-Techne shares in Q3 2022, an estimated $146K.
  • ARK Investment Management first reported a position in Bio-Techne in Q4 2021 and held it in 3 quarters.
  • ARK Investment Management's Bio-Techne position peaked at $195K in Q4 2021.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.